Enhanced lung cancer cell killing by the combination of selenium and ionizing radiation

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 209-216

  Shin, Sun Hye ^a   Yoon, Mi Jin ^a,b   Kim, Mira ^a   Kim, Jong Il ^b   Lee, Su Jae ^a   Lee, Yun Sil ^a   Bae, Sangwoo ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Seoul Women University   (South Korea)

Author keywords

Cell proliferation; DNA double strand break repair factors; Multi target approach; Radiosensitivity; Selenium

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN KINASE B; RAF PROTEIN; SELENOMETHIONINE;

ARTICLE; DRUG EFFECT; ENZYMOLOGY; HUMAN; LUNG TUMOR; METABOLISM; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; TUMOR CELL LINE;

CELL LINE, TUMOR; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-RAF; RADIATION TOLERANCE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SELENOMETHIONINE;

EID: 39049173930     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.209     Document Type: Article

References (31)

1. Kim YS and Milner J: Molecular targets for selenium in cancer prevention. Nutr Cancer 40: 50-54, 2001. (Pubitemid 34037514)
2. Combs GF Jr and Gray WP: Chemopreventive agents: selenium. Pharmacol Ther 79: 179-192, 1998.
3. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL and Taylor JR: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963, 1996. (Pubitemid 26427723)
4. Dong Y, Zhang H, Hawthorn L, Ganther HE and Ip C: Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res 63: 52-59, 2003. (Pubitemid 36070419)
5. Dong Y, Ganther HE, Stewart C, Ip C: Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res 62: 708-714, 2002. (Pubitemid 34126945)
6. Russell JS, Burgan W, Oswald KA, Camphausen K and Tofilon PJ: Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin: a multitarget approach to radiosensitization. Clin Cancer Res 9: 3749-3755, 2003. (Pubitemid 37169244)
7. Schueller P, Puettmann S, Micke O, Senner V, Schaefer U and Willich N: Selenium influences the radiation sensitivity of C6 rat glioma cells. Anticancer Res 24: 2913-2917, 2004. (Pubitemid 39407166)
8. Menter DG, Sabichi AL and Lippman SM: Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 9: 1171-1182, 2000.
9. Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR and Coltman C: The selenium and vitamin E cancer prevention trial. World J Urol 21: 21-27, 2003. (Pubitemid 44175292)
10. Park SH, Lee SJ, Chung HY, Kim TH, Cho CK, Yoo SY and Lee YS: Inducible heat-shock protein 70 is involved in the radioadaptive response. Radiat Res 153: 318-326. 2000.
11. Park MT, Choi JA, Kim MJ, Um HD, Bae S, Kang CM, Cho CK, Kang S, Chung HY, Lee YS and Lee SJ: Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J Biol Chem 278: 50624-50634, 2003. (Pubitemid 37548910)
12. Venkateswaran V, Klotz LH and Fleshner NE: Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. Cancer Res 62: 2540-2545, 2002. (Pubitemid 34462732)
13. Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942, 2004. (Pubitemid 38834285)
14. Lee SE, Mitchell RA, Cheng A and Hendrickson EA: Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol 17: 1425-1433, 1997. (Pubitemid 27097371)
15. Lieber MR, Ma Y, Pannicke U and Schwarz K: Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4: 712-720, 2003. (Pubitemid 37082186)
16. Redman C, Scott JA, Baines AT, Basye JL, Clark LC, Calley C, Roe D, Payne CM and Nelson MA: Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett 125: 103-110, 1998. (Pubitemid 28151916)
17. Kajander EO, Harvima RJ, Kauppinen L, Akerman KK, Martikainen H, Pajula RL and Karenlampi SO: Effects of selenomethionine on cell growth and on S-adenosylmethionine metabolism in cultured malignant cells. Biochem J 267: 767-774, 1990. (Pubitemid 20144168)
18. Brognard J, Clark AS, Ni Y and Dennis PA: Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61: 3986-3997, 2001. (Pubitemid 32720961)
19. Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ, Muschel RJ and McKenna WG: The Ras radiation resistance pathway. Cancer Res 61: 4278-4282, 2001. (Pubitemid 32721000)
20. Price BD and Youmell MB: The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res 56: 246-250, 1996. (Pubitemid 26026348)
21. Berger DH, Jardines LA, Chang H and Ruggeri B: Activation of Raf-1 in human pancreatic adenocarcinoma. J Surg Res 69: 199-204, 1997. (Pubitemid 27265850)
22. Riva C, Lavieille JP, Reyt E, Brambilla E, Lunardi J and Brambilla C: Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. Eur J Cancer B Oral Oncol 31B: 384-391, 1995. (Pubitemid 26009168)
23. Soldatenkov VA, Dritschilo A, Wang FH, Olah Z, Anderson WB and Kasid U: Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation. Cancer J Sci Am 3: 13-20, 1997.
24. Sartor CI: Biological modifiers as potential radiosensitizers: targeting the epidermal growth factor receptor family. Semin Oncol 27 (suppl 11): 15-20, 2000.
25. Wollman R, Yahalom J, Maxy R, Pinto J and Fuks Z: Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. Int J Radiat Oncol Biol Phys 30: 91-98, 1994. (Pubitemid 24291118)
26. Nasu S, Ang KK, Fan Z and Milas L: C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys 51: 474-477, 2001. (Pubitemid 32884294)
27. Williams KJ, Telfer BA, Stratford IJ and Wedge SR: ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. Br J Cancer 86: 1157-1161, 2002. (Pubitemid 34438090)
28. Cao S, Durrani FA and Rustum YM: Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 10: 2561-2569, 2004. (Pubitemid 38445719)
29. Mutlu-Turkoglu U, Erbil Y, Oztezcan S, Olgac V, Toker G and Uysal M: The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sci 66: 1905-1913, 2000. (Pubitemid 30213164)
30. Ip C: Lessons from basic research in selenium and cancer prevention. J Nutr 128: 1845-1854, 1998.
31. Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20: 1657-1666, 1999.